Insider Transactions in Q1 2025 at Biomarin Pharmaceutical Inc (BMRN)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2025
|
Charles Greg Guyer EVP, Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
7,034
-7.43%
|
$499,414
$71.28 P/Share
|
|
Feb 28
2025
|
Charles Greg Guyer EVP, Chief Technical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,287
-4.33%
|
$304,377
$71.16 P/Share
|
|
Feb 25
2025
|
Brian Mueller EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,067
+9.9%
|
-
|
|
Feb 25
2025
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,067
+11.69%
|
-
|
|
Feb 25
2025
|
Charles Greg Guyer EVP, Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,067
+10.17%
|
-
|
|
Feb 24
2025
|
Timothy P Walbert Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,130
+50.0%
|
-
|
|
Feb 24
2025
|
Erin Burkhart GVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,344
-9.3%
|
$91,392
$68.38 P/Share
|